Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eighteen research firms that are covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $45.06.
BBWI has been the subject of several research reports. JPMorgan Chase & Co. set a $47.00 target price on Bath & Body Works in a report on Thursday, February 27th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. TD Cowen increased their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $40.00 to $48.00 in a research report on Friday, February 28th. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th.
Get Our Latest Stock Report on BBWI
Institutional Trading of Bath & Body Works
Bath & Body Works Trading Up 4.0 %
NYSE:BBWI opened at $31.85 on Friday. The stock has a fifty day simple moving average of $34.84 and a 200-day simple moving average of $34.16. The company has a market cap of $6.82 billion, a price-to-earnings ratio of 7.77, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works has a twelve month low of $26.21 and a twelve month high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, equities research analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.
Bath & Body Works declared that its board has initiated a share repurchase program on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.
Bath & Body Works Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.51%. Bath & Body Works’s dividend payout ratio is currently 21.98%.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- 3 Small Caps With Big Return Potential
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- 5 discounted opportunities for dividend growth investors
- The 3 Most Talked About Investments on WallStreetBets Right Now
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.